Severe endothelial dysfunction in the aorta of a mouse model of Fabry disease; partial prevention by N-butyldeoxynojirimycin treatment.
OBJECTIVE: Fabry disease results from alpha-gala-ctosidase A deficiency and is characterized by the lysosomal accumulation of globotriaosylceramide. Globotriaosylceramide storage predominantly affects endothelial cells, altering vascular wall morphology and vasomotor function. Our objective was to i...
Những tác giả chính: | Heare, T, Alp, N, Priestman, D, Kulkarni, AB, Qasba, P, Butters, T, Dwek, R, Clarke, K, Channon, K, Platt, F |
---|---|
Định dạng: | Journal article |
Ngôn ngữ: | English |
Được phát hành: |
2007
|
Những quyển sách tương tự
-
N-butyldeoxynojirimycin causes weight loss as a result of appetite suppression in lean and obese mice.
Bằng: Priestman, D, et al.
Được phát hành: (2008) -
NSAIDs increase survival in the Sandhoff disease mouse: synergy with N-butyldeoxynojirimycin.
Bằng: Jeyakumar, M, et al.
Được phát hành: (2004) -
N-butyldeoxygalactonojirimycin: a more selective inhibitor of glycosphingolipid biosynthesis than N-butyldeoxynojirimycin, in vitro and in vivo.
Bằng: Andersson, U, et al.
Được phát hành: (2000) -
Long-term non-hormonal male contraception in mice using N-butyldeoxynojirimycin.
Bằng: Walden, C, et al.
Được phát hành: (2006) -
The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.
Bằng: Fischer, P, et al.
Được phát hành: (1995)